CD79A and juvenile idiopathic arthritis: Our study showed a similar prevalence for the SARS-CoV-2 IgG antibody and the SARS-CoV-2 IgA antibody in children with JIA and controls (IgG: 9.7% vs. 9.4%; IgA 4.8% vs. 6.3%, respectively).